Affordable Access

A pilot study of intraperitoneal cisplatin in the management of gastric cancer.

Authors
  • Jones, A L
  • Trott, P
  • Cunningham, D
  • Rosin, R D
  • Coleman, D
  • Sauven, P
  • Glazer, G
  • Cunningham, D
  • Hermon-Taylor, J
  • Coombes, R C
Type
Published Article
Journal
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
Publication Date
Feb 01, 1994
Volume
5
Issue
2
Pages
123–126
Identifiers
PMID: 8186154
Source
Medline
License
Unknown

Abstract

Cisplatin can be administered safely as adjuvant therapy to patients with gastric cancer, however, as single agent therapy the pattern of relapse and subsequent death was similar to that expected. The occurrence of distant metastases may argue for systemic rather than local adjuvant treatment.

Report this publication

Statistics

Seen <100 times